|
ATG16L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.74549263931567E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.8702999966288E-08 |
| Normal-vs-Stage2 |
2.143000E-03 |
| Normal-vs-Stage3 |
1.236650E-04 |
| Normal-vs-Stage4 |
9.000600E-03 |
| Stage1-vs-Stage2 |
2.372200E-01 |
| Stage1-vs-Stage3 |
2.746400E-02 |
| Stage1-vs-Stage4 |
4.934600E-01 |
| Stage2-vs-Stage3 |
3.204200E-01 |
| Stage2-vs-Stage4 |
8.556800E-01 |
| Stage3-vs-Stage4 |
2.250000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.47086812016551E-12 |
| Normal-vs-AfricanAmerican |
8.18780000000352E-05 |
| Normal-vs-Asian |
1.203980E-01 |
| Caucasian-vs-AfricanAmerican |
8.603200E-01 |
| Caucasian-vs-Asian |
6.006600E-01 |
| AfricanAmerican-vs-Asian |
7.233000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44704256857631E-12 |
| Normal-vs-Female |
4.62479999963072E-07 |
| Male-vs-Female |
9.885000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.076920E-03 |
| Normal-vs-Extreme_Weight |
3.42070000003414E-06 |
| Normal-vs-Obese |
4.63589999999403E-06 |
| Normal-vs-Extreme_Obese |
1.502020E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.235400E-01 |
| Normal_Weight-vs-Obese |
1.286420E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.836200E-01 |
| Extreme_Weight-vs-Obese |
1.795160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.266600E-01 |
| Obese-vs-Extreme_Obese |
7.830400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52553999999139E-05 |
| Normal-vs-Age(41-60Yrs) |
6.8987038304158E-12 |
| Normal-vs-Age(61-80Yrs) |
1.03860000044698E-07 |
| Normal-vs-Age(81-100Yrs) |
3.940200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.419800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.812110E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.356880E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.864800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.394000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.237400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.36186675456929E-12 |
| Normal-VS-Type2 PRCC |
1.206890E-04 |
| Normal-VS-KIRP CIMP |
1.998550E-04 |
| Normal-VS-Unclassified PRCC |
2.03049999999427E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.689600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.418700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.298600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.908000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.337200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.103000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.002300E-04 |
| Normal-vs-N1 |
1.032500E-04 |
| Normal-vs-N2 |
1.970770E-01 |
| N0-vs-N1 |
1.776220E-02 |
| N0-vs-N2 |
1.364160E-01 |
| N1-vs-N2 |
9.905600E-01 |
|
|
